Low-dose hydroxychloroquine use for long-term tied to low retinopathy risk: Study
Written By : Dr. Kamal Kant Kohli
Published On 2023-01-19 14:30 GMT | Update On 2023-01-19 14:30 GMT
Advertisement
USA: A recent study published in the Annals of Internal Medicine has found that patients who received hydroxychloroquine for five or more years with guideline-recommended serial retinopathy screening had a low overall risk for incident retinopathy, with most documented cases being mild. Higher hydroxychloroquine dose was linked with progressively greater risk.
"In the large, contemporary cohort of more than 3,000 people with active surveillance retinopathy screening, the overall risk for hydroxychloroquine retinopathy was 8.6% after 15 years, and the majority of cases were mild," the researchers wrote in their study. "Higher hydroxychloroquine dose was tied to progressively higher risk for incident retinopathy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.